These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23109605)

  • 1. Hypertrophic cardiomyopathy: diagnosis, risk stratification and treatment.
    Jacoby DL; DePasquale EC; McKenna WJ
    CMAJ; 2013 Feb; 185(2):127-34. PubMed ID: 23109605
    [No Abstract]   [Full Text] [Related]  

  • 2. Gaps in Evidence for Risk Stratification for Sudden Cardiac Death in Hypertrophic Cardiomyopathy.
    Pelliccia F; Gersh BJ; Camici PG
    Circulation; 2021 Jan; 143(2):101-103. PubMed ID: 33428428
    [No Abstract]   [Full Text] [Related]  

  • 3. A novel patient-patient network medicine approach to refine hypertrophic cardiomyopathy subgrouping: implications for risk stratification.
    Wang RS; Rowin EJ; Maron BJ; Maron MS; Maron BA
    Cardiovasc Res; 2023 May; 119(3):e125-e127. PubMed ID: 37129987
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of hypertrophic cardiomyopathy: what is the next step?
    Kuusisto J
    Heart; 2020 Sep; 106(17):1291-1292. PubMed ID: 32546508
    [No Abstract]   [Full Text] [Related]  

  • 5. Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart.
    Saberi S; Day SM
    Circulation; 2018 Jan; 137(5):419-421. PubMed ID: 29378753
    [No Abstract]   [Full Text] [Related]  

  • 6. Update on hypertrophic cardiomyopathy.
    Marian AJ
    Tex Heart Inst J; 2010; 37(3):322-3. PubMed ID: 20548812
    [No Abstract]   [Full Text] [Related]  

  • 7. State-of-the-art management of hypertrophic cardiomyopathy in children.
    Berger S; Dhala A; Dearani JA
    Cardiol Young; 2009 Nov; 19 Suppl 2():66-73. PubMed ID: 19857352
    [No Abstract]   [Full Text] [Related]  

  • 8. The never ending story of risk stratification for sudden death in hypertrophic cardiomyopathy.
    Christiaans I; Wilde AA
    Am J Cardiol; 2011 Jun; 107(12):1871. PubMed ID: 21640227
    [No Abstract]   [Full Text] [Related]  

  • 9. My approach to clinical management of hypertrophic cardiomyopathy.
    Maron MS
    Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674
    [No Abstract]   [Full Text] [Related]  

  • 10. MY APPROACH to the athlete with hypertrophic cardiomyopathy.
    Lampert R
    Trends Cardiovasc Med; 2019 Jul; 29(5):312. PubMed ID: 30928314
    [No Abstract]   [Full Text] [Related]  

  • 11. Hypertrophic Cardiomyopathy, Athlete's Heart, or Both: A Case of Hypertrophic Cardiomyopathy Regression.
    Kebed KY; Bos JM; Anavekar NS; Mulvagh SL; Ackerman MJ; Ommen SR
    Circ Cardiovasc Imaging; 2015 Jul; 8(7):e003312. PubMed ID: 26162782
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypertrophic cardiomyopathy.
    Ommen SR
    Curr Probl Cardiol; 2011 Nov; 36(11):409-53. PubMed ID: 21962729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypertrophic cardiomyopathy: evaluation and treatment of patients at high risk for sudden death.
    Fananapazir L; McAreavey D
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):478-501. PubMed ID: 9058851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of hypertrophic cardiomyopathy.
    Elliott PM; McKenna WJ
    Br J Hosp Med; 1996 Apr 3-16; 55(7):419-23. PubMed ID: 8730566
    [No Abstract]   [Full Text] [Related]  

  • 15. [Medical-legal evaluation of hypertrophic cardiomyopathy].
    Molisso C; Molisso M; De Cristofaro M
    G Ital Cardiol (Rome); 2010; 11(7-8):573-7. PubMed ID: 21033334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification in pediatric hypertrophic cardiomyopathy.
    Balaji S
    Heart Rhythm; 2024 Jan; 21(1):128-129. PubMed ID: 38176768
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertrophic cardiomyopathy: management issues in the new millennium.
    Thaman R; Firoozi S; Hamid MS; McKenna WJ
    Curr Cardiol Rep; 2002 May; 4(3):226-32. PubMed ID: 11960592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex differences in hypertrophic cardiomyopathy: Time to tailor risk stratification and therapy?
    Constantine A; Dimopoulos K; Rafiq I; Vazir A
    Eur J Prev Cardiol; 2020 Nov; 27(17):1816-1818. PubMed ID: 31795761
    [No Abstract]   [Full Text] [Related]  

  • 19. Are all non-sustained ventricular tachycardia the same in hypertrophic cardiomyopathy risk stratification for sudden cardiac death?
    Sabeh MK; Refaat MM
    J Cardiovasc Electrophysiol; 2020 Aug; 31(8):2099-2100. PubMed ID: 32437027
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy.
    Ommen SR; Nishimura RA
    Curr Probl Cardiol; 2004 May; 29(5):239-91. PubMed ID: 15123994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.